· Global leader in medical imaging analysis Quibim has joined Highlight Therapeutics, a clinical-stage company specializing in immuno-oncology, to assess…
Read More
Allows early detection of COVID-19 by radiologists through imaging biomarkers and is the main AI platform for screening for the…
Read More
QUIBIM is helping to advance knowledge of the most lethal pediatric tumors through EU-funded program PRIMAGE, which exploits precision information from medical imaging…
Read More
Pain, depression, slurred speech and feeling of numbness, tingling, or weakness. These are just some symptoms of Multiple Sclerosis (MS) disease, a…
Read More
